Involvement of histone deacetylation in MORC2-mediated down-regulation of carbonic anhydrase IX

Nucleic Acids Research

Volumn 38, Issue 9, 2010, Pages 2813-2824

  Shao, Yangguang ^a   Li, Yan ^a   Zhang, Jian ^a   Liu, Di ^a   Liu, Furong ^a   Zhao, Yue ^a   Shen, Tao ^a   Li, Feng ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; HISTONE DEACETYLASE 4; HISTONE H3; MICRORCHIDIA 2 PROTEIN; NUCLEAR PROTEIN; TRICHOSTATIN A; UNCLASSIFIED DRUG; CA9 PROTEIN, HUMAN; CARBONATE DEHYDRATASE; HDAC4 PROTEIN, HUMAN; HISTONE DEACETYLASE; MESSENGER RNA; MORC2 PROTEIN, HUMAN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR ANTIGEN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEACETYLATION; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; TRANSCRIPTION REGULATION; WESTERN BLOTTING; BINDING SITE; CELL LINE; DRUG ANTAGONISM; GENE SILENCING; GENETICS; METABOLISM;

ANTIGENS, NEOPLASM; BINDING SITES; CARBONIC ANHYDRASES; CELL LINE; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASES; HUMANS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 77953276827     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkq006     Document Type: Article

References (34)

1. Robertson, N., Potter, C. and Harris, A.L. (2004) Role of carbonic anhydrase IX in human tumor cell growth, survival and invasion. Cancer Res., 64, 6160-6165.
2. Potter, C. and Harris, A.L. (2004) Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survival pathway and therapy target. Cell Cycle, 3, 164-167.
3. Gut, M.O., Parkkila, S., Vernerová, Z., Rohde, E., Závada, J., Höcker, M., Pastorek, J., Karttunen, T., Gibadulinová, A., Závadová, Z. et al. (2002) Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology, 123, 1889-1903.
4. Driessen, A., Landuyt, W., Pastorekova, S., Moons, J., Goethals, L., Haustermans, K., Nafteux, P., Penninckx, F., Geboes, K., Lerut, T. et al. (2006) Expression of Carbonic Anhydrase IX (CA IX), a hypoxia-related protein, rather than Vascular-Endothelial Growth Factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas. Ann. Surg., 243, 334-340.
5. Airley, R.E., Loncaster, J., Raleigh, J.A., Harris, A.L., Davidson, S.E., Hunter, R.D., West, C.M. and Stratford, I.J. (2003) GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int. J. Cancer, 104, 85-91.
6. Liao, S.Y., Aurelio, O.N., Jan, K., Zavada, J. and Stanbridge, E.J. (1997) Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res., 57, 2827-2831.
7. Chia, S.K., Wykoff, C.C., Watson, P.H., Han, C., Leek, R.D., Pastorek, J., Gatter, K.C., Ratcliffe, P. and Harris, A.L. (2001) Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J. Clin. Oncol., 19, 3660-3668.
8. Tan, E.Y., Yan, M., Campo, L., Han, C., Takano, E., Turley, H., Candiloro, I., Pezzella, F., Gatter, K.C., Millar, E.K. et al. (2009) The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br. J. Cancer, 100, 405-411.
9. Schmitt, A., Barth, T.F., Beyer, E., Borchert, F., Rojewski, M., Chen, J., Guillaume, P., Gronau, S., Greiner, J., Möller, P. et al. (2009) The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses. Int. J. Oncol., 34, 629-639.
10. Beasley, N.J., Wykoff, C.C., Watson, P.H., Leek, R., Turley, H., Gatter, K., Pastorek, J., Cox, G.J., Ratcliffe, P. and Harris, A.L. (2001) Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res., 61, 5262-5267.
11. Swinson, D.E., Jones, J.L., Richardson, D., Wykoff, C., Turley, H., Pastorek, J., Taub, N., Harris, A.L. and O'Byrne, K.J. (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J. Clin. Oncol., 21, 473-482.
12. Proescholdt, M.A., Mayer, C., Kubitza, M., Wykoff, C., Turley, H., Pastorek, J., Taub, N., Harris, A.L. and O'Byrne, K.J. (2005) Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-Oncology, 7, 465-475.
13. Kaluz, S., Kaluzová, M., Liao, S.Y., Lerman, M. and Stanbridge, E.J. (2009) Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show? Biochim. Biophys. Acta, 1795, 162-172.
14. Leppilampi, M., Saarnio, J., Karttunen, T.J., Pastorek, J.K.S.P.J., Waheed, A., Sly, W.S. and Parkkila, S. (2003) Carbonic anhydrase isozymes IX and XII in gastric tumors. World J. Gastroenterol, 9, 1398-1403.
15. Griffiths, E.A., Pritchard, S.A., Welch, I.M., Price, P.M. and West, C.M. (2005) Is the hypoxia-inducible factor pathway important in gastric cancer? Eur. J. Cancer, 41, 2792-2805.
16. Chen, J., Röcken, C., Hoffmann, J., Krüger, S., Lendeckel, U., Rocco, A., Pastorekova, S., Malfertheiner, P. and Ebert, M.P. (2005) Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut, 54, 920-927.
17. Kaluz, S., Kaluzová, M., Opavský, R., Pastoreková, S., Gibadulinová, A., Dequiedt, F., Kettmann, R. and Pastorek, J. (1999) Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX. J. Biol. Chem., 274, 32588-32595.
18. Wykoff, C.C., Beasley, N.J., Watson, P.H., Turner, K.J., Pastorek, J., Sibtain, A., Wilson, G.D., Turley, H., Talks, K.L., Maxwell, P.H. et al. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res., 60, 7075-7083.
19. Kaluzová, M., Pastoreková, S., Svastová, E., Pastorek, J., Stanbridge, E.J. and Kaluz, S. (2001) Characterization of the MN/CA 9 promoter proximal region: a role for specificity protein (SP) and activator protein 1 (AP1) factors. Biochem. J., 359, 669-677.
20. Kaluz, S., Kaluzová, M. and Stanbridge, E.J. (2003) Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxiaresponsive enhancer. Cancer Res., 63, 917-922.
21. Grabmaier, K., A de Weijert, M.C., Verhaegh, G.W., Schalken, J.A. and Oosterwijk, E. (2004) Strict regulation of CAIX (G250/MN) by HIF-1alpha in clear cell renal cell carcinoma. Oncogene, 23, 5624-5631.
22. Perry, J. and Zhao, Y. (2003) The CW domain, a structural module shared amongst vertebrates, vertebrate-infecting parasites and higher plants. Trends Biochem. Sci., 28, 576-580.
23. Inoue, N., Hess, K.D., Moreadith, R.W., Richardson, L.L., Handel, M.A., Watson, M.L. and Zinn, A.R. (1999) New gene family defined by MORC, a nuclear protein required for mouse spermatogenesis. Hum. Mol. Genet., 8, 1201-1207.
24. Takahashi, K., Yoshida, N., Murakami, N., Kawata, K., Ishizaki, H., Tanaka-Okamoto, M., Miyoshi, J., Zinn, A.R., Shime, H. and Inoue, N. (2007) Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol. Biol. Cell, 18, 1701-1709.
25. Liggins, A.P., Cooper, C.D., Lawrie, C.H., Brown, P.J., Collins, G.P., Hatton, C.S., Pulford, K. and Banham, A.H. (2007) MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas. Br. J. Haematol., 138, 479-486.
26. Fuks, F. (2005) DNA methylation and histone modifications: teaming up to silence genes. Curr Opin. Genet. Dev., 15, 490-495.
27. Zhao, Y., Takeyama, K., Sawatsubashi, S., Ito, S., Suzuki, E., Yamagata, K., Tanabe, M., Kimura, S., Fujiyama, S., Ueda, T. et al. (2009) Corepressive action of CBP on androgen receptor transactivation in pericentric heterochromatin in a Drosophila experimental model system. Mol. Cell Biol., 29, 1017-1034.
28. Iyer, L.M., Abhiman, S. and Aravind, L. (2008) MutL homologs in restriction-modification systems and the origin of eukaryotic MORC ATPases. Biol. Direct., 3, 8.
29. Kaluzová, M., Kaluz, S., Lerman, M.I. and Stanbridge, E.J. (2004) DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1 alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Mol. Cell. Biol., 24, 5757-5766.
30. Cho, M., Uemura, H., Kim, S.C., Kawada, Y., Yoshida, K., Hirao, Y., Konishi, N., Saga, S. and Yoshikawa, K. (2001) Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma. Br. J. Cancer, 85, 563-567.
31. Cho, M., Grabmaier, K., Kitahori, Y., Hiasa, Y., Nakagawa, Y., Uemura, H., Hirao, Y., Ohnishi, T., Yoshikawa, K. and Ooesterwijk, E. (2000) Activation of the MN/CA9 gene is associated with hypomethylation carcinoma cell lines. Mol. Carcinog., 27, 184-189.
32. Ashida, S., Nishimori, I., Tanimura, M., Onishi, S. and Shuin, T. (2002) Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma. J. Cancer Res. Clin. Oncol., 128, 561-568.
33. Grabmaier, K., de Weijert, M., Uemura, H., Schalken, J. and Oosterwijk, E. (2002) Renal cell carcinoma-associated G250 methylation and expression: in vivo and in vitro studies. Urology, 60, 357-362.
34. Matsuoka, H., Fujimura, T., Hayashi, M., Matsuda, K., Ishii, Y., Aramori, I. and Mutoh, S. (2007) Disruption of HDAC4/N-CoR complex by histone deacetylase inhibitors leads to inhibition of IL-2 gene expression. Biochem. Pharmacol., 74, 465-476.